Financial statements Axon Lab
Balance sheet of Axon Lab
Company age:
Age:
23 y. 7 m. 24 d.
Share capital:
Share capital:
124 800 PLN
Balance sheet data of AXON LAB
|
Year
|
2021
|
2022
|
|---|---|---|
| Total assets | 19 057 356,23 | 20 235 801,60 |
| A. Fixed assets | 633 952,62 | 482 146,05 |
| B. Current assets | 18 423 403,61 | 19 753 655,55 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 19 057 356,23 | 20 235 801,60 |
| A. Equity | 14 079 777,87 | 15 117 505,92 |
| B. Liabilities and provisions for liabilities | 4 977 578,36 | 5 118 295,68 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 4 764 497,76 | 4 854 166,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.